Skip to search formSkip to main contentSkip to account menu

FK 664

Known as: FK-664, FK664 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyrimidinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Improved heart failure protection by FK664, a novel positive inotropic agent, in dog heart-lung preparations.
1992
1992
The effect of FK664, a new cardiovascular drug, on systemic capacitance vessels in anesthetized dogs.
1991
1991
X-ray structural studies and physicochemical characterization of (E)-6-(3,4-dimethoxyphenyl)-1-ethyl-4-mesitylimino-3-methyl- 3,4-dihydro-2(1H)-pyrimidinone polymorphs.
The polymorphism of (E)-6-(3,4-dimethoxyphenyl)-1-ethyl-4-mesitylimino-3-methyl-3,4-di hydro- 2(1 H)-pyrimidinone (FK664; 1) was… 
1989
1989
Electrophysiological effects of FK664, a new cardiotonic agent, on preparations from guinea pig ventricle and from rabbit sino-atrial node.
Effects of the cardiotonic agent FK664, 6-(3, 4-dimethoxy-phenyl)-1-ethyl-4-mesitylimino-3-methyl-3,4-dihydro-2 (1H)-pyrimidone… 
Review
1989
Review
1989
New Inotropic Agents for Treatment of Heart Failure
New positive inotropic agents have been synthesized and they are under intensive research to examine whether they are different… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)